Trial Profile
Intravitreal Injection of Conbercept for Macular Edema due to Branch Retinal Vein Occlusion: the Efficacy Analysis of Early versus Late
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2018
Price :
$35
*
At a glance
- Drugs Conbercept (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 17 Sep 2018 New trial record